Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRSP | PTGX | PTCT | ||
| Company | Crispr Therapeutics Ag | Protagonist Therapeutics Inc | Ptc Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 59.50 | 88.18 | 67.65 | ||
| High | 61.49 | 92.23 | 69.43 | ||
| Low | 58.50 | 87.15 | 67.28 | ||
| Latest | 60.14 | 92.08 | 68.19 | ||
| Change | -1.60 | +3.69 | +0.09 | ||
| % Change | -2.59% | +4.17% | +0.13% | ||
| Volume | 1,690,600 | 936,900 | 852,200 | ||
| 20-Day Average Volume | 1,715,315 | 632,230 | 1,185,795 | ||
| Previous Close | 61.74 | 88.39 | 68.10 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 52.48 | 84.29 | 71.29 | ||
| 20-Day Raw Stochastic | 90.02% | 99.02% | 27.24% | ||
| 20-Day Relative Strength | 58.73 | 63.92 | 37.73 | ||
| Weighted Alpha | +37.99 | +84.74 | +26.14 | ||
| Today's Opinion | 8% Buy | 88% Buy | 8% Buy | ||
| Previous Opinion | 8% Buy | 88% Buy | 8% Buy | ||
| Last Month's Opinion | 8% Sell | 40% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.50% since 02/20/26 | +11.26% since 02/20/26 | -3.50% since 02/20/26 | ||
| Low | 52.02 on 02/23/26 | 77.00 on 02/23/26 | 66.42 on 02/25/26 | ||
| High | 61.76 on 02/26/26 | 92.23 on 02/27/26 | 72.54 on 02/23/26 | ||
| 1-Month | |||||
| %Chg | +10.84% since 01/27/26 | +10.83% since 01/27/26 | -9.67% since 01/27/26 | ||
| Low | 45.53 on 02/05/26 | 77.00 on 02/23/26 | 64.67 on 02/20/26 | ||
| High | 61.76 on 02/26/26 | 92.23 on 02/27/26 | 78.38 on 01/28/26 | ||
| 3-Month | |||||
| %Chg | +12.83% since 11/26/25 | +2.23% since 11/26/25 | -20.94% since 11/26/25 | ||
| Low | 45.53 on 02/05/26 | 77.00 on 02/23/26 | 64.67 on 02/20/26 | ||
| High | 61.76 on 02/26/26 | 96.54 on 12/15/25 | 86.76 on 11/28/25 | ||
| 6-Month | |||||
| %Chg | +12.35% since 08/27/25 | +49.89% since 08/27/25 | +36.98% since 08/27/25 | ||
| Low | 45.53 on 02/05/26 | 54.50 on 09/09/25 | 48.96 on 08/29/25 | ||
| High | 78.48 on 10/08/25 | 96.54 on 12/15/25 | 87.50 on 11/26/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,772,538 | 5,875,532 | 5,644,428 | ||
| Shares Outstanding, K | 95,985 | 63,809 | 82,775 | ||
| Annual Sales | 3,510,000 | 434,430,000 | 1,730,660,000 | ||
| Annual Net Income | -581,600,000 | 275,190,000 | 682,640,000 | ||
| Last Quarter Sales | 860,000 | 4,710,000 | 164,680,000 | ||
| Last Quarter Net Income | -130,610,000 | -39,340,000 | -134,970,000 | ||
| 60-Month Beta | 1.72 | 2.26 | 0.48 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.37 on 02/12/26 | -0.62 on 11/06/25 | -1.67 on 02/19/26 | ||
| Latest Earnings Date | 05/05/26 | 05/05/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 8.81 | ||